Abstract
Historically, detailed studies of rare congenital platelet defects have provided unique insights into key proteins involved in human platelet function. In this issue of Blood, Berrou et al use advanced genomic sequencing/functional analysis to identify a novel role for ephrin transmembrane receptor subclass B2 (EPHB2) in regulating platelet activation.
Original language | English |
---|---|
Pages (from-to) | 2002-2004 |
Number of pages | 3 |
Journal | Blood |
Volume | 132 |
Issue number | 19 |
DOIs | |
Publication status | Published - 8 Nov 2018 |